Evidence map›Paper›PMID 40146411›Full record

ArticleJournal of robotic surgery2025

Preliminary results of feasibility, safety and efficacy of robotic assisted laparoscopic pyeloplasty with the SHURUI single-port robotic surgical platform in children.

Yangyue Huang, Weiping Zhang, Hongcheng Song, Yuzhu He, DeFu Lin, Minglei Li, Ning Li, Chao Liu, Wenwen Han

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yangyue HuangDepartment of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China.
Weiping ZhangDepartment of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China.
Hongcheng SongDepartment of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China.
Yuzhu HeDepartment of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China.
DeFu LinDepartment of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China.
Minglei LiDepartment of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China.
Ning LiDepartment of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China.
Chao Liu *Department of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China. liuchao1515@163.com.
Wenwen Han *Department of Pediatric Urology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nan Li Shi Street, Beijing, 100045, China. hww_bch@163.com.

Funding

the Science and Technology Planning Program of Beijing Municipal Science & Technology Commission and Administrative Commission of Zhongguancun Science Park Z231100004823034
6 · The paper itself

Abstract

This study aims to evaluate the feasibility, safety and efficacy of robotic assisted laparoscopic pyeloplasty (RALP) with the novel SHURUI single-port (SR-SP) robotic surgical platform in children. Between November 2023 and April 2024, 20 pediatric patients diagnosed with ureteropelvic junction obstruction (UPJO) underwent transperitoneal RALP with the SR-SP surgical platform. Baseline characteristics, perioperative parameters and follow-up data were collected and analyzed. All surgical procedures were successfully performed without conversion to open or laparoscopic surgery. The median docking time, console time, and operative time were 3.5 min (range 3.5-6.0), 144.5 min (range 88.0-290.0), and 221.5 min (range 136.0-450.0), respectively. The median estimated blood loss was 5 ml (range 2-20) and the median length of hospital stays was 6 days (range 4-24). Through trans-umbilical incision, RALP was feasible in patients with a height of no less than 114 cm. The minimum incision length was 2 cm. No intraoperative complication was identified. Two cases were identified with the Clavien-Dindo Grade II postoperative complications and one with the Clavien-Dindo Grade III complications. The surgical success rate was 95%. The median SCAR scale score for incision scars was 2 points (range 1-3). Surgeons reported a favorable technical difficulty rating with a National Aeronautics and Space Administration Task Load Index (NASA-TLX) score of 30.7. RALP using the novel SR-SP robotic surgical platform is feasible, safe and effective in older children. The SR-SP surgical platform may serve as a promising alternative to the da Vinci SP surgical platform.

Indexed as

Kidney PelvisLaparoscopyRobotic Surgical ProceduresUreteral ObstructionUrologic Surgical ProceduresAdolescentBlood Loss, SurgicalChildChild, PreschoolFeasibility StudiesFemaleHumansInfantLength of StayMaleOperative TimeRobotic assisted laparoscopic pyeloplastyThe SHURUI single portUreteropelvic junction obstruction

Identifiers

PMID40146411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.